Research suggests that Type 2 diabetes could have debilitating effect on patients.

Despite treatment advances, kidney disease burden remained unchanged over the past decade ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

Common diabetes myths debunked by doctors ...

A review highlights hearing loss as a hidden complication of type 2 diabetes. It notes that roughly 1 in 4 experience hearing ...

Type 1.5 diabetes is often mistaken for type 2. Here is how to tell the difference and why the diagnosis matters.

Chronic kidney disease (CKD) is common, largely silent and serious. Most people who have the condition do not realize they ...

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who ...

Novo Nordisk launched Awiqli, a once-weekly insulin, in India to treat type 1 and 2 diabetes. It aims to reduce injection ...

Veterinarian Dr. John Kaya explains how diabetes affects cats, what warning signs owners should watch for, and what treatment ...